{"transactions":[{"id":1119908,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":78795,"kind":"person","name":"Elling Christian E","position":1,"cik":"0001891306","reported_name":"Elling Christian E","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:25:55.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":35144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":35144,"derivative":{"exercise_price":1.5,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":35144},"source":{"system":"sec-edgar","filing":"0000905148-25-002030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514825002030/form4.xml","form_type":"4"}},{"id":1487109,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":78795,"kind":"person","name":"Elling Christian E","position":1,"cik":"0001891306","reported_name":"Elling Christian E","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:14:19.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":45642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":45642,"derivative":{"exercise_price":1.25,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":45642},"source":{"system":"sec-edgar","filing":"0000905148-24-001683","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514824001683/form4.xml","form_type":"4"}},{"id":1810031,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":78795,"kind":"person","name":"Elling Christian E","position":1,"cik":"0001891306","reported_name":"Elling Christian E","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2023-08-12T01:24:23.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":7901234,"price":0.125,"value":987654.25,"ownership":{"direct":false,"nature":"Lundbeckfond Invest A/S"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held of record by Lundbeckfond Invest A/S. The Reporting Person is Managing Partner of Lundbeckfonden Emerge, a division of Lundbeckfond Invest A/S. The Reporting Person disclaims beneficial ownership of the securities held by Lundbeckfond Invest A/S except to the extent of his pecuniary interest therein, if any."}],"balance_after":7901234,"derivative":{"exercise_price":2.47,"exercise_date":"2023-08-09","underlying":"Common Stock","underlying_shares":7901234},"source":{"system":"sec-edgar","filing":"0001140361-23-039346","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123039346/form4.xml","form_type":"4"}},{"id":1810030,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":78795,"kind":"person","name":"Elling Christian E","position":1,"cik":"0001891306","reported_name":"Elling Christian E","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-12T01:24:23.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":7901234,"price":1.9,"value":15012344.6,"ownership":{"direct":false,"nature":"Lundbeckfond Invest A/S"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held of record by Lundbeckfond Invest A/S. The Reporting Person is Managing Partner of Lundbeckfonden Emerge, a division of Lundbeckfond Invest A/S. The Reporting Person disclaims beneficial ownership of the securities held by Lundbeckfond Invest A/S except to the extent of his pecuniary interest therein, if any."}],"balance_after":13950686,"source":{"system":"sec-edgar","filing":"0001140361-23-039346","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123039346/form4.xml","form_type":"4"}},{"id":1857407,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":78795,"kind":"person","name":"Elling Christian E","position":1,"cik":"0001891306","reported_name":"Elling Christian E","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T23:54:32.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":41533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 8, 2024, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":41533,"derivative":{"exercise_price":2.075,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":41533},"source":{"system":"sec-edgar","filing":"0001140361-23-029694","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123029694/form4.xml","form_type":"4"}},{"id":2251619,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":78795,"kind":"person","name":"Elling Christian E","position":1,"cik":"0001891306","reported_name":"Elling Christian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T23:36:38.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":23885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on May 26, 2023, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":23885,"derivative":{"exercise_price":4.85,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":23885},"source":{"system":"sec-edgar","filing":"0001567619-22-011960","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000156761922011960/doc1.xml","form_type":"4"}}]}